Pulmonary heart disease

Pulmonary heart disease

Right ventricular hypertrophy
Classification and external resources
Specialty Pulmonology
ICD-10 I26, I27
ICD-9-CM 415.0
MedlinePlus 000129
MeSH D011660

Pulmonary heart disease, also known as cor pulmonale is the enlargement and failure of the right ventricle of the heart as a response to increased vascular resistance (such as from pulmonic stenosis) or high blood pressure in the lungs [1]

Chronic pulmonary heart disease usually results in right ventricular hypertrophy (RVH),[2] whereas acute pulmonary heart disease usually results in dilatation.[3] Hypertrophy is an adaptive response to a long-term increase in pressure. Individual muscle cells grow larger (in thickness) and change to drive the increased contractile force required to move the blood against greater resistance. Dilatation is a stretching (in length) of the ventricle in response to acute increased pressure.[4]

To be classified as pulmonary heart disease, the cause must originate in the pulmonary circulation system. Two causes are vascular changes as a result of tissue damage (e.g. disease, hypoxic injury), and chronic hypoxic pulmonary vasoconstriction. If left untreated, then death may result, RVH due to a systemic defect is not classified as pulmonary heart disease.The heart and lungs are intricately related; whenever the heart is affected by disease, the lungs will follow and vice versa. Pulmonary heart disease is by definition a condition when the lungs cause the heart to fail.

Signs and symptoms
Wheezing
The sound of wheezing as heard with a stethoscope.
Problems playing this file? See media help.

The symptoms/signs of pulmonary heart disease (cor pulmonale) can be non-specific and depend on the stage of the disorder, and can include blood backing up into the systemic venous system, including the hepatic vein[5][6] As pulmonary heart disease progresses, most individuals will develop symptoms like:[7]

Causes

Blood clot[8]

The causes of pulmonary heart disease (cor pulmonale) are the following:

Pathophysiology

The pathophysiology of pulmonary heart disease (cor pulmonale) has always indicated that an increase in right ventricular afterload causes RV failure (pulmonary vasoconstriction, anatomic disruption/pulmonary vascular bed and increased blood viscosity are usually involved [7]), however most of the time, the right ventricle adjusts to an overload in chronic pressure.According to Voelkel, et al., pressure overload is the initial step for changes in RV, other factors include:[13]

Diagnosis

Normal heart (left) and right ventricular hypertrophy (right)

The diagnosis of pulmonary heart disease is not easy as both lung and heart disease can produce similar symptoms. Therefore, the differential diagnosis should assess:[14]

Among the investigations available to determine cor pulmonale are:[7]

Prevention

In terms of the prevention of cor pulmonale, while not all lung diseases can be prevented one can reduce the risk of lung disease, this means avoiding or discontinuing smoking. Patients with emphysema or chronic obstructive lung disease end up with right heart failure.[1][15]

Treatment

The treatment for cor pulmonale includes the following:antibiotics, expectorants, oxygen therapy, diuretics, digitalis, vasodilators, and anticoagulants.Some studies have indicated that Shenmai injection with conventional treatment is safe and effective for cor pulmonale (chronic).[16]

Treatment requires diuretics (to decrease strain on the heart).[7]Oxygen is often required to resolve the shortness of breath. Additionally, oxygen to the lungs also helps relax the blood vessels and eases right heart failure.[17] When wheezing is present,the majority of individuals require a bronchodilator.[7] A variety of drugs have been developed to relax the blood vessels in the lung, calcium channel blockers are used [18] but only work in few cases and according to NICE are not recommended for use at all.[19]

Anticoagulants are used when venous thromboembolism is present. Venesection is used in severe secondary polycythaemia (because of hypoxia), which improves symptoms though survival rate has not been proven to increase.Finally, transplantation of single/double lung in extreme cases of cor pulmonale is also an option.[7]

Epidemiology

The epidemiology of pulmonary heart disease (cor pulmonale) accounts for 7% of all heart disease in the U.S.[14] According to Weitzenblum, et al., the mortality that is related to cor pulmonale is not easy to ascertain, as it is a complication of COPD.[20]

References

  1. 1 2 3 4 5 6 7 8 9 "Cor pulmonale: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Retrieved 2015-12-21.
  2. ↑ Voelkel, Norbert F.; Quaife, Robert A.; Leinwand, Leslie A.; Barst, Robyn J.; McGoon, Michael D.; Meldrum, Daniel R.; Dupuis, Jocelyn; Long, Carlin S.; Rubin, Lewis J. (2006-10-24). "Right Ventricular Function and Failure Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure". Circulation 114 (17): 1883–1891. doi:10.1161/CIRCULATIONAHA.106.632208. ISSN 0009-7322. PMID 17060398.
  3. ↑ Matthews, Jennifer Cowger; McLaughlin, Vallerie (2008-02-01). "Acute Right Ventricular Failure in the Setting of Acute Pulmonary Embolism or Chronic Pulmonary Hypertension: A Detailed Review of the Pathophysiology, Diagnosis, and Management". Current Cardiology Reviews 4 (1): 49–59. doi:10.2174/157340308783565384. ISSN 1573-403X. PMC 2774585. PMID 19924277.
  4. ↑ "Types of Cardiomyopathy - NHLBI, NIH". www.nhlbi.nih.gov. Retrieved 2015-12-22.
  5. ↑ George, Ronald B. (2005-01-01). Chest Medicine: Essentials of Pulmonary and Critical Care Medicine. Lippincott Williams & Wilkins. p. 226. ISBN 9780781752732.
  6. ↑ "Medscape Log In". www.medscape.com. Retrieved 2015-12-22.
  7. 1 2 3 4 5 6 "Cor Pulmonale. Pulmonary heart disease information. Patient | Patient". Patient. Retrieved 2015-12-22.
  8. ↑ "Blood clots: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Retrieved 2015-12-22.
  9. ↑ Nixon, J. V. (2010-10-18). The AHA Clinical Cardiac Consult. Lippincott Williams & Wilkins. p. 136. ISBN 9781608316229.
  10. ↑ Wilkins, Lippincott Williams & (2009-01-01). Professional Guide to Diseases. Lippincott Williams & Wilkins. p. 139. ISBN 9780781778992.
  11. ↑ O'Malley, Paul D. (2006-01-01). New Developments in Sickle Cell Disease Research. Nova Publishers. p. 214. ISBN 9781594547928.
  12. ↑ MacDonald, Mhairi G.; Seshia, Mary M. K.; Mullett, Martha D. (2005-01-01). Avery's Neonatology: Pathophysiology & Management of the Newborn. Lippincott Williams & Wilkins. p. 699. ISBN 9780781746434.
  13. ↑ Voelkel, Norbert F.; Gomez-Arroyo, Jose; Abbate, Antonio; Bogaard, Harm J. (2013-01-01). "Mechanisms of right heart failure—A work in progress and a plea for failure prevention". Pulmonary Circulation 3 (1): 137–143. doi:10.4103/2045-8932.109957. ISSN 2045-8932. PMC 3641721. PMID 23662190.
  14. 1 2 "Cor Pulmonale: Introduction to Cor Pulmonale, Etiology and Pathophysiology of Cor Pulmonale, Epidemiology of Cor Pulmonale".
  15. ↑ "Chronic obstructive pulmonary disease: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Retrieved 2015-12-22.
  16. ↑ Shi, Liwei; Xie, Yanming; Liao, Xing; Chai, Yan; Luo, Yanhua (2015-11-24). "Shenmai injection as an adjuvant treatment for chronic cor pulmonale heart failure: a systematic review and meta-analysis of randomized controlled trials". BMC Complementary and Alternative Medicine 15. doi:10.1186/s12906-015-0939-2. ISSN 1472-6882. PMC 4659214. PMID 26603978.
  17. ↑ George, Ronald B. (2005-01-01). Chest Medicine: Essentials of Pulmonary and Critical Care Medicine. Lippincott Williams & Wilkins. p. 227. ISBN 9780781752732.
  18. ↑ "Calcium Channel Blockers". livertox.nih.gov. Retrieved 2015-12-22.
  19. ↑ "Calcium channel blockers are not recommended for the treatment of cor pulmonale. | NICE". www.nice.org.uk. Retrieved 2015-12-22.
  20. ↑ Weitzenblum, Emmanuel (2003-02-01). "CHRONIC COR PULMONALE". Heart 89 (2): 225–230. ISSN 1355-6037. PMC 1767533. PMID 12527688.

Further reading

This article is issued from Wikipedia - version of the Tuesday, January 12, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.